Pathology News
Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the development and commercialization of advanced diagnostic tools aimed at expanding precision medicine. Leveraging DHR’s newly...
From the Aiosyn Blog IVDR represents a significant overhaul of regulations requiring more rigorous oversight, clinical validation assessed by a Notified Body, and stricter post-market surveillance (PMS). Aiosyn’s AI-powered...
Aiforia Technologies has appointed pathologist Richard Doughty (MD, DVM, MSc) as the Medical Director of the company. Aiforia Technologies Plc, Press Release, May 26, 2025 at 10:00 a.m. EEST Aiforia Technologies has appointed...
A case study from Diagnexia The global shortage of pathologists has posed significant challenges for healthcare providers, increasing workloads, leading to backlogs, and delaying critical diagnoses. To address these challenges, East...
Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, announced on May 23 that 12 studies featuring its AI-powered digital pathology solution will be presented at the 2025 American Society of Clinical Oncology...
It’s Time to Re-Read Player Piano
- Anatomic Pathology
- Artificial Intelligence
- Books
- Business
- Clinical Laboratories
- Clinical Pathology
- Current Affairs
- Device Manufacturers
- Digital Pathology News
- Education
- FDA Approval
- Histology
- Informatics
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- New Digital Imaging Technologies
- Pathology News
- Personal
- TeleHealth
- Web/Tech
"The main business of humanity is to do a good job of being human beings," said Paul, "not to serve as appendages to machines, institutions, and systems." If you have not read Player Piano, it is a good read. I read it many years ago...































